FDA issues new recommendations on feeding tube use
By
Marty Stempniak
Sep 12, 2018
Providers should take extra precautions when using feeding tubes, according to new guidance from the Food and Drug Administration.
Infection fighters: FDA, APIC put spotlight on nurses, drug development in fight against drug resistance
By
Kimberly Marselas
Jun 13, 2018
The Food and Drug Administration on Tuesday released draft guidelines that should make it easier to develop new antibiotics and antifungal drugs, one facet of a multi-pronged approach to limiting antimicrobial...
FDA approves digital antipsychotic pill to track patient data
By
Nov 14, 2017
A new type of antipsychotic pill approved by the Food and Drug Administration will be able to share information about when it was taken with patients and providers — but it comes with a warning for older...
Implant provides hope for the limping
By
Elizabeth Newman
Jul 29, 2016
In one of the sadder coincidences of my life, news of an FDA-approved cartilage implant made me more excited than it would have a year ago. That’s because this particular synthetic cartilage implant...
FDA approves first biosimilar treatment
By
Elizabeth Newman
Apr 06, 2015
The Food and Drug Administration approved its first biosimilar product in March, opening the door for more costly drug alternatives.
FDA approves ‘breakthrough’ therapy for diabetic eye disorder
By
John Hall
Mar 26, 2015
The FDA announced Wednesday that it has granted “breakthrough therapy designation” to the drug Eylea, and expanded its approved use for the treatment of diabetic retinopathy in patients with...
FDA panel approves first biosimilar drug
Mar 10, 2015
The Food and Drug Administration approved its first biosimilar product last week, opening the door for more costly drug alternatives.
Another state considers terminally ill access to experimental drugs
By
John Hall
Mar 10, 2015
Despite opposition from some drug makers and provider groups, Illinois lawmakers are considering several bills that would allow terminal patients to try unapproved experimental drugs to extend their lives.
Assisted living residents with dementia receiving too many antipsychotics, GAO says
By
John Hall
Mar 03, 2015
Government investigators are calling for greater scrutiny of antipsychotics use among dementia patients in post-acute settings beyond nursing homes.
FDA approves extended-release opioid painkiller
By
Elizabeth Newman
Nov 21, 2014
The U.S. Food and Drug Administration gave market clearance to an extended-release opioid painkiller yesterday. It is designed for those with severe pain.